Kay D. Beharry

2.2k total citations
111 papers, 1.7k citations indexed

About

Kay D. Beharry is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kay D. Beharry has authored 111 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 42 papers in Pediatrics, Perinatology and Child Health and 38 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kay D. Beharry's work include Neonatal Respiratory Health Research (50 papers), Retinopathy of Prematurity Studies (30 papers) and Neonatal and fetal brain pathology (23 papers). Kay D. Beharry is often cited by papers focused on Neonatal Respiratory Health Research (50 papers), Retinopathy of Prematurity Studies (30 papers) and Neonatal and fetal brain pathology (23 papers). Kay D. Beharry collaborates with scholars based in United States, Canada and United Kingdom. Kay D. Beharry's co-authors include Jacob V. Aranda, Houchang D. Modanlou, Gloria B. Valencia, Sylvain Chemtob, J Rex, Charles L. Cai, Daya R. Varma, Douglas R. Lazzaro, N Laudignon and Joshua Waltzman and has published in prestigious journals such as Circulation Research, PEDIATRICS and Stroke.

In The Last Decade

Kay D. Beharry

110 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kay D. Beharry United States 23 738 509 503 288 274 111 1.7k
Patrizio Fiorini Italy 18 373 0.5× 319 0.6× 448 0.9× 44 0.2× 184 0.7× 32 1.1k
Jesper Thulesen Denmark 22 265 0.4× 180 0.4× 68 0.1× 193 0.7× 285 1.0× 47 2.1k
Ayşe Bi̇lgi̇han Türkiye 21 140 0.2× 214 0.4× 47 0.1× 238 0.8× 197 0.7× 76 1.4k
Özlem Gülbahar Türkiye 22 208 0.3× 67 0.1× 161 0.3× 80 0.3× 269 1.0× 132 1.6k
Alfons J.H.M. Houben Netherlands 23 142 0.2× 180 0.4× 115 0.2× 41 0.1× 139 0.5× 83 1.8k
Jean‐Claude Lavoie Canada 28 890 1.2× 35 0.1× 760 1.5× 105 0.4× 350 1.3× 86 2.1k
Anita C. Truttmann Switzerland 25 405 0.5× 85 0.2× 601 1.2× 49 0.2× 458 1.7× 61 1.8k
James C. Melby United States 29 301 0.4× 76 0.1× 94 0.2× 54 0.2× 569 2.1× 117 2.9k
Girija G. Konduri United States 30 2.1k 2.8× 52 0.1× 406 0.8× 513 1.8× 583 2.1× 94 3.1k
Isabel Torres-Cuevas Spain 17 264 0.4× 28 0.1× 292 0.6× 111 0.4× 431 1.6× 38 1.2k

Countries citing papers authored by Kay D. Beharry

Since Specialization
Citations

This map shows the geographic impact of Kay D. Beharry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay D. Beharry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay D. Beharry more than expected).

Fields of papers citing papers by Kay D. Beharry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay D. Beharry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay D. Beharry. The network helps show where Kay D. Beharry may publish in the future.

Co-authorship network of co-authors of Kay D. Beharry

This figure shows the co-authorship network connecting the top 25 collaborators of Kay D. Beharry. A scholar is included among the top collaborators of Kay D. Beharry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay D. Beharry. Kay D. Beharry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Charles L., et al.. (2024). Gut microbiome and inflammation in response to increasing intermittent hypoxia in the neonatal rat. Pediatric Research. 97(6). 2126–2135. 1 indexed citations
2.
Cai, Charles L., et al.. (2024). Early versus late caffeine and/or non‐steroidal anti‐inflammatory drugs (NSAIDS) for prevention of intermittent hypoxia‐induced neuroinflammation in the neonatal rat. International Journal of Developmental Neuroscience. 84(3). 227–250. 2 indexed citations
3.
Cai, Charles L., et al.. (2024). Comparison of Glutathione Nanoparticles, CoEnzyme Q10, and Fish Oil for Prevention of Oxygen-Induced Retinopathy in Neonatal Rats. Pharmaceuticals. 17(3). 381–381. 1 indexed citations
4.
Cai, Charles L., et al.. (2023). Coenzyme Q10 and Fish Oil Supplementation for Reducing Retinal Oxidative Stress in a Rat Model. Vision. 7(1). 20–20. 2 indexed citations
5.
Yazdanyar, Amirfarbod, Charles L. Cai, Jacob V. Aranda, Eric Shrier, & Kay D. Beharry. (2023). Comparison of Bevacizumab and Aflibercept for Suppression of Angiogenesis in Human Retinal Microvascular Endothelial Cells. Pharmaceuticals. 16(7). 939–939. 2 indexed citations
6.
Beharry, Kay D., et al.. (2023). Factors Influencing Neonatal Gut Microbiome and Health with a Focus on Necrotizing Enterocolitis. Microorganisms. 11(10). 2528–2528. 13 indexed citations
7.
8.
Cai, Charles L., et al.. (2021). Antioxidants and/or fish oil reduce intermittent hypoxia-induced inflammation in the neonatal rat terminal ileum. Prostaglandins & Other Lipid Mediators. 155. 106565–106565. 2 indexed citations
9.
Cai, Charles L., et al.. (2021). Comparison of coenzyme Q10 or fish oil for prevention of intermittent hypoxia-induced oxidative injury in neonatal rat lungs. Respiratory Research. 22(1). 196–196. 5 indexed citations
10.
Cai, Charles L., et al.. (2021). Dose Response of Bumetanide on Aquaporins and Angiogenesis Biomarkers in Human Retinal Endothelial Cells Exposed to Intermittent Hypoxia. Pharmaceuticals. 14(10). 967–967. 1 indexed citations
11.
Cai, Charles L., et al.. (2021). Renal biomarkers of acute kidney injury in response to increasing intermittent hypoxia episodes in the neonatal rat. BMC Nephrology. 22(1). 299–299. 5 indexed citations
12.
Cai, Charles L., et al.. (2021). Growth factors in the fetus and pre-adolescent offspring of hyperglycemic rats. Diabetes and Vascular Disease Research. 18(2). 1476853713–1476853713. 2 indexed citations
13.
Cai, Charles L., et al.. (2021). Pharmacodynamic Effects of Standard versus High Caffeine Doses in the Developing Brain of Neonatal Rats Exposed to Intermittent Hypoxia. International Journal of Molecular Sciences. 22(7). 3473–3473. 8 indexed citations
14.
Cai, Charles L., et al.. (2021). Effects of omega 3 polyunsaturated fatty acids, antioxidants, and/or non‐steroidal inflammatory drugs in the brain of neonatal rats exposed to intermittent hypoxia. International Journal of Developmental Neuroscience. 81(5). 448–460. 6 indexed citations
15.
16.
Cai, Charles L., et al.. (2020). Bumetanide Suppression of Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy. International Journal of Molecular Sciences. 21(3). 987–987. 6 indexed citations
17.
Duggan, Thomas J., Charles L. Cai, Jacob V. Aranda, & Kay D. Beharry. (2020). Acute and chronic effects of intravitreal bevacizumab on lung biomarkers of angiogenesis in the rat exposed to neonatal intermittent hypoxia. Experimental Lung Research. 47(3). 1–15. 6 indexed citations
18.
19.
Beharry, Kay D., et al.. (2018). Oxygen-Induced Retinopathy from Recurrent Intermittent Hypoxia Is Not Dependent on Resolution with Room Air or Oxygen, in Neonatal Rats. International Journal of Molecular Sciences. 19(5). 1337–1337. 12 indexed citations
20.
Hausman, Nicole L., Kay D. Beharry, Kenji Nishihara, Yasir Akmal, & Tamerou Asrat. (2003). Effect of the antenatal administration of celecoxib during the second and third trimesters of pregnancy on prostaglandin, cytokine, and nitric oxide levels in rabbits. American Journal of Obstetrics and Gynecology. 189(6). 1737–1743. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrizio Fiorini Breakdown of academic impact, for papers by Jesper Thulesen Breakdown of academic impact, for papers by Ayşe Bi̇lgi̇han Breakdown of academic impact, for papers by Özlem Gülbahar Breakdown of academic impact, for papers by Alfons J.H.M. Houben Breakdown of academic impact, for papers by Jean‐Claude Lavoie Breakdown of academic impact, for papers by Anita C. Truttmann Breakdown of academic impact, for papers by James C. Melby Breakdown of academic impact, for papers by Girija G. Konduri Breakdown of academic impact, for papers by Isabel Torres-Cuevas
Rankless by CCL
2026